Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaofei Jiao

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Biochemical Pharmacology|June 25, 2025
ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosisShen-Nan Shi, Qiuyang Xu, Xiaofei Jiao, et al.
Biochemical Pharmacology|April 14, 2025
Withdrawal notice to: ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosisShen-Nan Shi, Qiuyang Xu, Xiaofei Jiao, et al.
Nutrients|July 14, 2023
Awareness and Use of Low-Sodium Salt Substitutes and Its Impact on 24-h Urinary Sodium and Potassium Excretion in China-A Cross-Sectional StudyPuhong Zhang, Fang Fan, Yinghua Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2024
BRCA1 safeguards genome integrity by activating chromosome asynapsis checkpoint to eliminate recombination-defective oocytesLong Bai, Peng Li, Yu Xiang, et al.
Environmental Toxicology|November 8, 2019
The toxic effects of Fluorene-9-bisphenol on porcine oocyte in vitro maturationXiaofei Jiao, Zhiming Ding, Fei Meng, et al.
Science Translational Medicine|August 13, 2025
Sequential treatment with PARPi and WEE1i enhances antitumor immune responses in preclinical models of ovarian cancerXiaofei Jiao, Jiahao Liu, Yijie Wu, et al.
BMJ Open|September 15, 2022
Oncological big data platforms for promoting digital competencies and professionalism in Chinese medical students: a cross-sectional studyJiahao Liu, Xiaofei Jiao, Shaoqing Zeng, et al.
BMJ Open|May 25, 2022
Sintilimab combined with bevacizumab in relapsed/persistent ovarian clear cell carcinoma (INOVA): an investigator-initiated, multicentre clinical trial-a study protocol of clinical trialRuyuan Li, Xingyu Liu, Chunyan Song, et al.
Journal of Ovarian Research|June 27, 2023
Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgeryGuanchen Ma, Shaoqing Zeng, Yingjun Zhao, et al.
Science Translational Medicine|May 7, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacyJiahao Liu, Xiaofei Jiao, Wei Mu, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Biochemical Pharmacology|June 25, 2025
ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosisShen-Nan Shi, Qiuyang Xu, Xiaofei Jiao, et al.
Biochemical Pharmacology|April 14, 2025
Withdrawal notice to: ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosisShen-Nan Shi, Qiuyang Xu, Xiaofei Jiao, et al.
Nutrients|July 14, 2023
Awareness and Use of Low-Sodium Salt Substitutes and Its Impact on 24-h Urinary Sodium and Potassium Excretion in China-A Cross-Sectional StudyPuhong Zhang, Fang Fan, Yinghua Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2024
BRCA1 safeguards genome integrity by activating chromosome asynapsis checkpoint to eliminate recombination-defective oocytesLong Bai, Peng Li, Yu Xiang, et al.
Environmental Toxicology|November 8, 2019
The toxic effects of Fluorene-9-bisphenol on porcine oocyte in vitro maturationXiaofei Jiao, Zhiming Ding, Fei Meng, et al.
Science Translational Medicine|August 13, 2025
Sequential treatment with PARPi and WEE1i enhances antitumor immune responses in preclinical models of ovarian cancerXiaofei Jiao, Jiahao Liu, Yijie Wu, et al.
BMJ Open|September 15, 2022
Oncological big data platforms for promoting digital competencies and professionalism in Chinese medical students: a cross-sectional studyJiahao Liu, Xiaofei Jiao, Shaoqing Zeng, et al.
BMJ Open|May 25, 2022
Sintilimab combined with bevacizumab in relapsed/persistent ovarian clear cell carcinoma (INOVA): an investigator-initiated, multicentre clinical trial-a study protocol of clinical trialRuyuan Li, Xingyu Liu, Chunyan Song, et al.
Journal of Ovarian Research|June 27, 2023
Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgeryGuanchen Ma, Shaoqing Zeng, Yingjun Zhao, et al.
Science Translational Medicine|May 7, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacyJiahao Liu, Xiaofei Jiao, Wei Mu, et al.
Pageof 4